MONTREAL --
Quebec doctors will receive a recommendation early this week from a provincial drug evaluation committee on whether they should prescribe the medication colchicine to treat non-hospitalized COVID-19 patients.
The update comes after a tumultuous week that started with a prominent Montreal Heart Institute (MHI) researcher making bold claims in a press release about the effectiveness of the medication and ended with pushback after many scientists were eventually able to scrutinize the study’s data themselves.
“We anticipate making our interim position public at the beginning of the week, Tuesday being very likely,” National Institute for Excellence in Health and Social Services (INESSS)spokesperson Olivia Jacques told CTV in an email.